Economic analyses of blood safety and transfusion medicine interventions: A systematic review

被引:24
作者
Custer, B [1 ]
机构
[1] Blood Ctr Pacific, San Francisco, CA 94118 USA
关键词
D O I
10.1016/j.tmrv.2003.12.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Economic evaluations are increasingly common in blood safety and transfusion medicine. We sought to summarize and review economic evaluations of donated blood interventions conducted in the United States. By using computer database searches, we identified 19 studies that reported both cost and health benefit results, and relative to each other, we rated the quality of their design and reporting. We classified 6 of the studies as having high quality, 10 as having fair quality, and 3 as having poor quality. Several strengths and limitations in economic evaluations of blood safety and transfusion medicine interventions were identified. Four key improvements can increase the quality of literature in this discipline. We believe researchers should (1) provide more explicit detail on cost parameters in each study and the methods used to obtain them; (2) adopt a clear analysis perspective relevant to decision makers that captures all key costs and consequences, such as the societal perspective; (3) use a consistent approach to reporting sensitivity analyses; and (4) place greater reliance on graphical presentation of results including sensitivity analyses because a large amount of information can be conveyed in relatively simple figures, leaving space to discuss the impact of important analysis assumptions and applicability of the results to other settings. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 143
页数:17
相关论文
共 50 条
[1]   SAFETY AND COST-EFFECTIVENESS OF SOLVENT-DETERGENT-TREATED PLASMA - IN SEARCH OF A ZERO-RISK BLOOD-SUPPLY [J].
AUBUCHON, JP ;
BIRKMEYER, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (15) :1210-1214
[2]   Safety of the blood supply in the United States: Opportunities and controversies [J].
AuBuchon, JP ;
Birkmeyer, JD ;
Busch, MP .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) :904-909
[3]   Lessons learned from decision analysis [J].
AuBuchon, JP .
TRANSFUSION, 1996, 36 (08) :755-760
[4]   Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood [J].
AuBuchon, JP ;
Birkmeyer, JD ;
Busch, MP .
TRANSFUSION, 1997, 37 (01) :45-51
[5]   A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion [J].
AuBuchon, JP ;
Littenberg, B .
TRANSFUSION, 1996, 36 (03) :222-226
[6]   THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION FOR TOTAL HIP AND KNEE REPLACEMENT [J].
BIRKMEYER, JD ;
GOODNOUGH, LT ;
AUBUCHON, JP ;
NOORDSIJ, PG ;
LITTENBERG, B .
TRANSFUSION, 1993, 33 (07) :544-551
[7]   COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS DONATION IN CORONARY-ARTERY BYPASS-GRAFTING [J].
BIRKMEYER, JD ;
AUBUCHON, JP ;
LITTENBERG, B ;
OCONNOR, GT ;
NEASE, RF ;
NUGENT, WC ;
GOODNOUGH, LT .
ANNALS OF THORACIC SURGERY, 1994, 57 (01) :161-169
[8]  
*BUR LAB STAT, 2001, CONS PRIC IND MED CA
[9]   Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections [J].
Busch, MP ;
Dodd, RY ;
Lackritz, EM ;
AuBuchon, JP ;
Birkmeyer, JD ;
Petersen, LR .
TRANSFUSION, 1997, 37 (10) :1003-1011
[10]   Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection [J].
Busch, MP ;
Korelitz, JJ ;
Kleinman, SH ;
Lee, SR ;
AuBuchon, JP ;
Schreiber, GB ;
Williams, AE ;
Ownby, HE ;
Waxman, DA ;
Hutching, S ;
Murphy, EL ;
Gilcher, RO ;
Smith, JW ;
Thomson, RA ;
Nemo, GJ ;
Zuck, TF .
TRANSFUSION, 1995, 35 (11) :903-910